Cargando…
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study
INTRODUCTION: Opioid agonist treatment is effective for opioid dependence and newer extended-release buprenorphine (BUP-XR) injections represent a significant development. The Community Long-Acting Buprenorphine (CoLAB) study aims to evaluate client outcomes among people with opioid dependence recei...
Autores principales: | Larance, Briony, Byrne, Marianne, Lintzeris, Nicholas, Nielsen, Suzanne, Grebely, Jason, Degenhardt, Louisa, Shahbazi, Jeyran, Shanahan, Marian, Lancaster, Kari, Dore, Gregory, Ali, Robert, Farrell, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398105/ https://www.ncbi.nlm.nih.gov/pubmed/32737087 http://dx.doi.org/10.1136/bmjopen-2019-034389 |
Ejemplares similares
-
Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
por: Peacock, Amy, et al.
Publicado: (2018) -
Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020) -
Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
por: Larney, Sarah, et al.
Publicado: (2014) -
Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
por: Jumah, Naana Afua, et al.
Publicado: (2016) -
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
por: Lowry, Natalie, et al.
Publicado: (2022)